Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy

DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy

Aimmune Therapeutics Announces Initiation of Phase 2 Study of AR101 With...

Phase II Trials of AR101 with Dupilumab for Peanut Allergy to...

Company Developing Peanut Immunotherapy Toothpaste Meets with FDA

FDA Grants Fast Track Designation for Epinephrine Nasal Spray as Investigational...

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

Epinephrine Nasal Spray for Anaphylaxis Shows Promise as Potential Alternative to...

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate

Follow Us

Your School On Our Map

Put Your School on the Map